Pilot Study on Device-assisted Mobilisation of Critically Ill Patients
Launched by CHARITE UNIVERSITY, BERLIN, GERMANY · Jan 28, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how a special device, called the Liana® mobilizer, can help critically ill patients who need breathing support to become more active during their recovery. The goal is to see if using this device allows patients to reach a higher level of mobility, such as standing, more often than usual. The researchers believe that this could not only help patients regain strength faster but also make it easier for healthcare staff to assist them. Additionally, they want to find out if patients feel positively about using the device during their treatment.
To participate in this study, patients need to be at least 18 years old, currently receiving breathing support in the intensive care unit (ICU), and expected to stay in the ICU for at least another two days. However, some patients may not be eligible, such as those with severe injuries, certain health conditions, or those who have just had surgery. If someone participates, they will be randomly assigned to either use the Liana® mobilizer or receive standard care, and the study will track how this impacts their recovery and mobility. This trial is currently looking for participants who meet the criteria.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Intensive care patient with ventilatory support and an expected intensive care stay of at least another 48 h
- • Age ≥ 18 years
- • Current length of intensive care stay \< 48 h
- Exclusion Criteria:
- • Moribund and critically ill
- • Suspected 6-month mortality \> 75%.
- • Increased intracranial pressure
- • Critically ill after cardiopulmonary resuscitation
- • Critically ill with primary neuromuscular disease or motor neuron disease
- • One or more amputated extremities
- • Patients, within 2h after surgery
- • Unstable fractures
- • Severe traumatic brain injury (e.g., brain and skull injuries)
- • Circulatory instability with norepinephrine \> 0.3 µg/kg/min
- • Patients for whom there is an indication for deep sedation (RASS -5)
- • Language barrier
- • Fitting of legs into leg trays is not possible due to e.g. patient weight
About Charite University, Berlin, Germany
Charité - Universitätsmedizin Berlin is a leading academic medical center in Germany, renowned for its commitment to excellence in research, education, and patient care. As one of Europe's largest university hospitals, Charité integrates cutting-edge clinical practices with innovative research initiatives, fostering interdisciplinary collaboration across various medical fields. The institution is dedicated to advancing healthcare through rigorous clinical trials, contributing to the development of new therapies and treatment protocols. With a strong emphasis on translational medicine, Charité aims to bridge the gap between scientific discovery and practical application, ultimately enhancing patient outcomes and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Berlin, , Germany
Patients applied
Trial Officials
Stefan J Schaller, MD
Principal Investigator
Charite University, Berlin, Germany
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials